LLY241206C510000
- 0.00
- 0.000.00%
Eli Lilly and Co Newsroom
Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $994
Eli Lilly & Co (LLY) Gets a Buy From Jefferies
Technology stocks have become the market leader! Will the Pioneer Growth ETF outperform the s&p 500 again in 2025?
The Vanguard Growth etf has a strong record of outperforming the s&p 500, having surpassed this index on average every year since its establishment in 2004.
Why Is Eli Lilly and Company (LLY) Among Louis Navellier's Top Stock Picks Heading Into 2025?
The strongest competitor's data is not good, will the 'weight-loss duo' continue to dominate?
Analysts believe that if Amgen's weight loss drug could achieve a 20% weight loss effect a few years ago, it would have been the best among similar products, but now Eli Lilly and Co and Novo-Nordisk A/S pipeline drugs may achieve or exceed a 25% weight loss effect. Currently, dozens of pharmaceutical companies are actively entering the weight loss drug market, but none have shown the potential to truly challenge the 'weight loss giants'.
Eli Lilly and Novo Nordisk's Obesity Moat Just Got Stronger -- Heard on the Street -- WSJ
S&P 500 Posts Weekly Rise to Fresh Record, Ends November With Strongest Monthly Gain of Year
10 Health Care Stocks With Whale Alerts In Today's Session
Trump 'sells off' European pharmaceutical stocks, can only rely on 'Americanization' to stop the decline?
The growth prescription for European pharmaceutical companies: shifting towards the usa.
Behind the Scenes of Eli Lilly's Latest Options Trends
Jefferies Financial: Trump's return is bullish for growth stocks, with the top 10 having the greatest upside.
Jefferies financial strategists expect that Trump's re-election as president will encourage investors to continue pursuing growth stocks, suggesting that investors avoid value stocks.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
Express News | In the first 10 months of this year, the number of newly established foreign-funded enterprises in peking increased by 13.3% year-on-year.
The Trump economic team may have internal discord, and the key agenda still needs the "understanding king" to make the final decision!
Analysts state that the Trump team's characterization of the economic policy as 'the opponent team' is almost accurate, and the strong opposition between Besant and Lutnik has been publicly reported.
Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%
U.S. stocks early market | Core PCE has the largest increase since April of this year! Spot gold briefly dropped; quantum computing concept stocks are booming! QUBT and RGTI rose by 10%, and Quantum once triggered a circuit breaker.
The market continues to focus on Trump's tariff policy and cabinet composition. The actual GDP growth rate of the United States in the third quarter slowed down compared to the second quarter.
Eli Lilly's Flortaucipir Approved by UK Regulator to Test for Alzheimer's Disease
LLY, NVO Stock Up as Biden Proposes Medicare Cover for Obesity Drugs
Express News | Mhra: Approves Flortaucipir (Tauvid) for Adults Showing Signs of Cognitive Impairment for Alzheimer’s Disease